Cas no 1182284-45-2 (4-(Chloromethyl)-1-methylpiperidine hydrochloride)
4-(Chloromethyl)-1-methylpiperidine hydrochloride Chemical and Physical Properties
Names and Identifiers
-
- 4-(Chloromethyl)-1-methylpiperidine Hydrochloride
- Piperidine, 4-(chloromethyl)-1-methyl-,hydrochloride (1:1)
- 4-(Chloromethyl)-1-methylpiperidine HCl
- 0048AD
- TRA0075807
- SY026785
- AM804001
- AB0072079
- 4-(Chloromethyl)-1-methylpiperidineHydrochloride
- 4-(chloromethyl)-1-methylpiperidine;hydrochloride
- 4-(Chloromethyl)-1-methylpiperidine hydrochloride (1:1)
- 4-(Chloromethyl)-1-methylpiperidine--hydrogen chloride (1/1)
- CS-0075760
- MFCD12923013
- FT-0728988
- AKOS015958738
- 4-(Chloromethyl)-1-methylpiperidine hydrochloride, AldrichCPR
- F2167-0015
- DTXSID90613845
- 1182284-45-2
- SCHEMBL1991435
- SB41176
- CS-11623
- A893195
- EN300-237885
- DA-14967
- 4-(Chloromethyl)-1-methylpiperidine hydrochloride
-
- MDL: MFCD12923013
- Inchi: 1S/C7H14ClN.ClH/c1-9-4-2-7(6-8)3-5-9;/h7H,2-6H2,1H3;1H
- InChI Key: NIXLUDKORJXUEV-UHFFFAOYSA-N
- SMILES: ClCC1CCN(C)CC1.Cl
Computed Properties
- Exact Mass: 183.05800
- Monoisotopic Mass: 183.0581549g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 1
- Heavy Atom Count: 10
- Rotatable Bond Count: 1
- Complexity: 77
- Covalently-Bonded Unit Count: 2
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 3.2
Experimental Properties
- PSA: 3.24000
- LogP: 2.30690
4-(Chloromethyl)-1-methylpiperidine hydrochloride Customs Data
- HS CODE:2933399090
- Customs Data:
China Customs Code:
2933399090Overview:
2933399090. Other compounds with non fused pyridine rings in structure. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
4-(Chloromethyl)-1-methylpiperidine hydrochloride Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | 077243-5g |
4-(Chloromethyl)-1-methylpiperidine hydrochloride |
1182284-45-2 | 5g |
20483CNY | 2021-05-07 | ||
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | 077243-500mg |
4-(Chloromethyl)-1-methylpiperidine hydrochloride |
1182284-45-2 | 500mg |
5461CNY | 2021-05-07 | ||
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | 077243-1g |
4-(Chloromethyl)-1-methylpiperidine hydrochloride |
1182284-45-2 | 1g |
6827CNY | 2021-05-07 | ||
| Alichem | A129007418-5g |
4-(Chloromethyl)-1-methylpiperidine hydrochloride |
1182284-45-2 | 95% | 5g |
$523.00 | 2023-09-04 | |
| Alichem | A129007418-25g |
4-(Chloromethyl)-1-methylpiperidine hydrochloride |
1182284-45-2 | 95% | 25g |
$773.22 | 2023-09-04 | |
| TRC | C382645-50mg |
4-(Chloromethyl)-1-methylpiperidine Hydrochloride |
1182284-45-2 | 50mg |
$ 70.00 | 2022-06-06 | ||
| TRC | C382645-100mg |
4-(Chloromethyl)-1-methylpiperidine Hydrochloride |
1182284-45-2 | 100mg |
$ 95.00 | 2022-06-06 | ||
| TRC | C382645-500mg |
4-(Chloromethyl)-1-methylpiperidine Hydrochloride |
1182284-45-2 | 500mg |
$ 340.00 | 2022-06-06 | ||
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | D852204-1g |
4-(Chloromethyl)-1-methylpiperidine Hydrochloride |
1182284-45-2 | ≥97% | 1g |
808.20 | 2021-05-17 | |
| Apollo Scientific | OR930858-250mg |
4-(Chloromethyl)-1-methylpiperidine hydrochloride |
1182284-45-2 | 98% | 250mg |
£64.00 | 2024-05-25 |
4-(Chloromethyl)-1-methylpiperidine hydrochloride Related Literature
-
Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
-
M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990
-
J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
-
Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
Additional information on 4-(Chloromethyl)-1-methylpiperidine hydrochloride
Professional Introduction to 4-(Chloromethyl)-1-methylpiperidine hydrochloride (CAS No. 1182284-45-2)
4-(Chloromethyl)-1-methylpiperidine hydrochloride, with the chemical formula C?H??Cl?N·HCl, is a significant compound in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the piperidine class, which is well-documented for its versatile applications in drug development. The presence of a chloromethyl group and a methylpiperidine core makes it a valuable intermediate in synthesizing various pharmacologically active molecules.
The CAS number 1182284-45-2 uniquely identifies this chemical entity, ensuring precise classification and reference in scientific literature. Its hydrochloride salt form enhances stability and solubility, making it more suitable for various experimental and industrial applications. The compound’s structure imparts unique reactivity, particularly the chloromethyl group, which is often utilized in nucleophilic substitution reactions to introduce complex molecular frameworks.
In recent years, 4-(Chloromethyl)-1-methylpiperidine hydrochloride has garnered attention in the development of novel therapeutic agents. Researchers have explored its potential in creating small-molecule inhibitors targeting specific biological pathways. For instance, studies have highlighted its role in synthesizing compounds that interact with enzyme active sites, potentially leading to treatments for neurological disorders and infectious diseases. The piperidine moiety’s ability to mimic natural amino acid structures has been particularly useful in designing peptidomimetics.
One of the most compelling aspects of this compound is its utility in constructing heterocyclic scaffolds. Heterocycles are fundamental components of many drugs due to their ability to optimize pharmacokinetic properties such as bioavailability and metabolic stability. The methylpiperidine ring in 4-(Chloromethyl)-1-methylpiperidine hydrochloride provides a rigid yet flexible backbone, allowing chemists to attach diverse functional groups while maintaining structural integrity. This flexibility has been leveraged in the synthesis of kinase inhibitors, which play a crucial role in cancer therapy.
Advances in computational chemistry have further enhanced the understanding of 4-(Chloromethyl)-1-methylpiperidine hydrochloride’s reactivity. Molecular modeling studies have predicted optimal reaction conditions for its transformation into more complex derivatives. These predictions have been validated experimentally, demonstrating the compound’s efficacy as a building block in drug discovery pipelines. The chloromethyl group’s electrophilic nature makes it particularly susceptible to nucleophilic attack, enabling the construction of carbon-carbon bonds essential for drug molecule assembly.
The pharmaceutical industry has also explored derivatives of 4-(Chloromethyl)-1-methylpiperidine hydrochloride for their potential antimicrobial properties. Modifications to the piperidine ring have led to compounds exhibiting activity against resistant bacterial strains. This aligns with global efforts to combat antibiotic resistance by developing novel antibiotics with unique mechanisms of action. The compound’s structural features allow for fine-tuning of pharmacological profiles, making it adaptable to various therapeutic needs.
Moreover, 4-(Chloromethyl)-1-methylpiperidine hydrochloride has found applications beyond traditional drug development. Its role as a ligand in coordination chemistry has been investigated, particularly in designing metal-organic frameworks (MOFs) with catalytic properties. These MOFs can be tailored for specific chemical transformations, offering sustainable alternatives to conventional synthetic methods. The compound’s ability to chelate metal ions has opened new avenues for material science research.
Recent clinical trials have begun to explore the therapeutic potential of 4-(Chloromethyl)-1-methylpiperidine hydrochloride derivatives in treating neurodegenerative diseases. Preliminary data suggest that certain modifications can enhance crossing the blood-brain barrier, a critical challenge in CNS drug delivery. The piperidine scaffold’s compatibility with biological membranes makes it an attractive candidate for developing neuroprotective agents.
The synthesis of 4-(Chloromethyl)-1-methylpiperidine hydrochloride itself is an area of active research. Optimizing production methods ensures cost-effective scalability while maintaining high purity standards necessary for pharmaceutical applications. Green chemistry principles have been applied to reduce waste and energy consumption during manufacturing processes, aligning with global sustainability goals.
In conclusion, 4-(Chloromethyl)-1-methylpiperidine hydrochloride (CAS No. 1182284-45-2) represents a multifaceted compound with broad implications across pharmaceuticals and materials science. Its unique structural features enable diverse applications, from drug development to catalysis and beyond. As research continues to uncover new possibilities, this compound remains a cornerstone in synthetic chemistry and medicinal innovation.
1182284-45-2 (4-(Chloromethyl)-1-methylpiperidine hydrochloride) Related Products
- 64099-45-2(3-(chloromethyl)-1-azabicyclo2.2.2octane)
- 801144-27-4(Piperidine,4,4-bis(2-chloroethyl)-1-methyl-)
- 52694-50-5(3-(chloromethyl)-1-methyl-Piperidine)
- 3187-26-6(4,4-bis(2-chloroethyl)-1-methylpiperidine;hydrochloride)
- 52694-51-6(4-(chloromethyl)-1-methylpiperidine)
- 88598-77-0(1-Azabicyclo[2.2.2]octane, 3-(chloromethyl)-, (S)-)
- 137658-54-9(Piperidine, 3-(chloromethyl)-1-ethyl-, hydrochloride)
- 748771-30-4(Piperidine, 4-(3-chloropropyl)-1-methyl-)
- 86014-80-4(3-(chloromethyl)quinuclidine;hydrochloride)
- 66496-82-0(3-chloromethyl-1-methylpiperidine hydrochloride)